Many third-party payers are now basing reimbursement on procedures and diagnostics that align with evidence-based 'best practices.' But medicine is an art in which judgement also applies, as well as the impact of your particular skills as a diagnostician or your technical prowess in doing procedures. Nevertheless, 'evidence-based medicine' is here to stay, even if is based on a Gaussian distribution that doesn't take into account the 'outliers' under the bell curve. For these, thinking outside of the curve is still needed, and you should say that.